KindlyMD, Inc. (NASDAQ:NAKA) Receives $30.00 Average Target Price from Analysts

Shares of KindlyMD, Inc. (NASDAQ:NAKA) have been given a consensus recommendation of “Hold” by the five analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $30.00.

NAKA has been the subject of several analyst reports. Maxim Group cut their price target on shares of KindlyMD from $60.00 to $30.00 and set a “buy” rating for the company in a report on Monday, April 6th. Weiss Ratings raised KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Wall Street Zen raised KindlyMD to a “sell” rating in a report on Saturday, May 23rd. Finally, TD Cowen started coverage on KindlyMD in a research report on Friday, April 10th. They issued a “buy” rating and a $40.00 price objective for the company.

Insider Buying and Selling at KindlyMD

In other KindlyMD news, CEO David F. Bailey purchased 55,115 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was acquired at an average cost of $5.62 per share, with a total value of $309,746.30. Following the completion of the acquisition, the chief executive officer directly owned 3,175,476 shares of the company’s stock, valued at $17,846,175.12. This represents a 1.77% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired 191,448 shares of company stock valued at $992,908 in the last three months. Company insiders own 24.49% of the company’s stock.

Institutional Investors Weigh In On KindlyMD

Hedge funds have recently added to or reduced their stakes in the stock. Stratos Wealth Partners LTD. bought a new position in shares of KindlyMD in the fourth quarter worth about $1,571,000. Sagespring Wealth Partners LLC bought a new stake in shares of KindlyMD during the fourth quarter valued at approximately $28,000. Virtu Financial LLC bought a new stake in shares of KindlyMD during the fourth quarter valued at approximately $151,000. Invesco Ltd. acquired a new stake in shares of KindlyMD in the fourth quarter valued at approximately $211,000. Finally, NewEdge Advisors LLC acquired a new stake in shares of KindlyMD in the fourth quarter valued at approximately $316,000.

KindlyMD Price Performance

Shares of NAKA stock opened at $4.87 on Friday. The stock’s fifty day simple moving average is $4.69 and its 200 day simple moving average is $8.95. KindlyMD has a one year low of $3.33 and a one year high of $659.20. The firm has a market cap of $84.74 million, a price-to-earnings ratio of -0.11 and a beta of 16.05.

KindlyMD (NASDAQ:NAKA) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.38) earnings per share (EPS) for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%.The company had revenue of $2.68 million for the quarter. On average, research analysts anticipate that KindlyMD will post -16.8 earnings per share for the current year.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.